EP3283882
BLOOD-BASED BIOMARKERS OF TUMOR SENSITIVITY TO PD-1 ANTAGONISTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.4.2016EP published:
16.12.2020EP application number:
16780526.6
EPO information:
European Patent Register
Max expiry date:
11.4.2036
Title:
BLOOD-BASED BIOMARKERS OF TUMOR SENSITIVITY TO PD-1 ANTAGONISTS
Timeline
Today
12.4.2016EP application
16.12.2020EP Publication
Owner
Name:
Merck Sharp & Dohme Corp.Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, US
Inventor
Name:
AYERS, MarkAddress:
West Point, Pennsylvania 19486, US
Name:
LUNCEFORD, JaredAddress:
Washington, Utah 84780, US
Name:
LOBODA, AndreyAddress:
Boston, Massachusetts 02115-5727, US
Name:
NEBOZHYN, MichaelAddress:
West Point, Pennsylvania 19486, US
Name:
MCCLANAHAN, Terrill, K.Address:
Palo Alto, California 94304, US
Name:
HIRSCH, HeatherAddress:
Brookline, Massachusetts 02445, US
Priority
Number:
201562149333 PDate:
17.4.2015Country:
US
Classification
Categories:
G01N 33/543, G01N 33/566, G01N 33/574, G01N 33/68